Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Undisclosed anti-CD52 monoclonal antibody / Sinopharm
NCT05557903: Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL	Recruiting	1	71	RoW	Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection, Anti-CD52 Monoclonal Antibody	Lanzhou Institute of Biological Products Co., Ltd	Lymphoma, Non-Hodgkin, Lymphoma, T-Cell	12/22	06/23